Distinctive morphology of renal cell carcinomas in tuberous sclerosis

International Journal of Surgical Pathology

Volumn 18, Issue 5, 2010, Pages 409-418

  Schreiner, Andrew ^a,c   Daneshmand, Siamak ^b   Bayne, Aaron ^b,d   Countryman, Gayle ^a   Corless, Christopher L ^a   Troxell, Megan L ^a  

^a Section of Urologic Oncology   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

angiomyolipoma; renal cell carcinoma; tuberous sclerosis complex

Indexed keywords

CREATININE; HAMARTIN; KERATIN; MELAN A; MONOCLONAL ANTIBODY HMB 45; TUBERIN; VIMENTIN;

ADULT; ANGIOMYOLIPOMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOPLASM; EOSINOPHIL; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY INJURY; MALE; MORPHOLOGY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX;

ADULT; ANGIOLIPOMA; CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KIDNEY NEOPLASMS; MALE; NEOPLASMS, MULTIPLE PRIMARY; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 78549250782     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896909333510     Document Type: Article

References (37)

1. Crino PB, Nathanson KL, Henske EP The tuberous sclerosis complex. N Engl J Med. 2006 ; 355: 1345-1356.
2. Bissler JJ, Kingswood JC Renal angiomyolipomata. Kidney Int. 2004 ; 66: 924-934.
3. Yeung RS Lessons from the Eker rat model: from cage to bedside. Curr Mol Med. 2004 ; 4: 799-806.
4. Rakowski SK, Winterkorn EB, Paul E., Steele DJ, Halpern EF, Thiele EA Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 2006 ; 70: 1777-1782.
5. Eble JN, Amin MB, Young RH Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol. 1997 ; 21: 1123-1130.
6. Martignoni G., Pea M., Bonetti F., et al. Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol. 1998 ; 22: 663-672.
7. Pea M., Bonetti F., Martignoni G., et al. Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol. 1998 ; 22: 180-187.
8. Bjornsson J., Short MP, Kwiatkowski DJ, Henske EP Tuberous sclerosis-associated renal cell carcinoma: clinical, pathological, and genetic features. Am J Pathol. 1996 ; 149: 1201-1208.
9. Jimenez RE, Eble JN, Reuter VE, et al. Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases. Mod Pathol. 2001 ; 14: 157-163.
10. Corsenca A., Aebersold F., Moch H., et al. Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages. Nephrol Dial Transplant. 2007 ; 22: 3330-3333.
11. Al-Saleem T., Wessner LL, Scheithauer BW, et al. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998 ; 83: 2208-2216.
12. Henske EP The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked ? Curr Mol Med. 2004 ; 4: 825-831.
13. Henske EP Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatr Nephrol. 2005 ; 20: 854-857.
14. Wu A., Kunju LP, Cheng L., Shah RB Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation- associated and unusual clear cell subtypes. Histopathology. 2008 ; 53: 533-544.
15. Bruder E., Passera O., Harms D., et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004 ; 28: 1117-1132.
16. Martignoni G., Pea M., Rocca PC, Bonetti F. Renal pathology in the tuberous sclerosis complex. Pathology. 2003 ; 35: 505-512.
17. Hino O. Multistep renal carcinogenesis in the Eker (Tsc 2 gene mutant) rat model. Curr Mol Med. 2004 ; 4: 807-811.
18. Eker R., Mossige J., Johannessen JV, Aars H. Hereditary renal adenomas and adenocarcinomas in rats. Diagn Histopathol. 1981 ; 4: 99-110.
19. Yeung RS, Xiao GH, Jin F., Lee WC, Testa JR, Knudson AG Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A. 1994 ; 91: 11413-11416.
20. Kobayashi T., Hirayama Y., Kobayashi E., Kubo Y., Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet. 1995 ; 9: 70-74.
21. Wolf DC, Whiteley HE, Everitt JI Preneoplastic and neoplastic lesions of rat hereditary renal cell tumors express markers of proximal and distal nephron. Vet Pathol. 1995 ; 32: 379-386.
22. Cook JD, Walker CL The Eker rat: establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma. Curr Mol Med. 2004 ; 4: 813-824.
23. Wilson C., Idziaszczyk S., Parry L., et al. A mouse model of tuberous sclerosis 1 showing background specific early postnatal mortality and metastatic renal cell carcinoma. Hum Mol Genet. 2005 ; 14: 1839-1850.
24. Eble JN, Sauter G., Epstein JI, Sesterhenn IA Tumours of the kidney. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Tumours of the Urinary System and Male Genital Organs: World Health Organization Classification of Tumours: Pathology & Genetics. Lyon, France: IARC Press. 2004: 1-43.
25. Davis CJ, Barton JH, Sesterhenn IA Cystic angiomyolipoma of the kidney: a clinicopathologic description of 11 cases. Mod Pathol. 2006 ; 19: 669-674.
26. Fine SW, Reuter VE, Epstein JI, Argani P. Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma. Am J Surg Pathol. 2006 ; 30: 593-599.
27. Argani P., Olgac S., Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007 ; 31: 1149-1160.
28. Skinnider BF, Amin MB An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol. 2005 ; 22: 51-68.
29. Lee L., Sudentas P., Donohue B., et al. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer. 2005 ; 42: 213-227.
30. El-Hashemite N., Zhang H., Henske EP, Kwiatkowski DJ Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet. 2003 ; 361: 1348-1349.
31. Kenerson HL, Aicher LD, True LD, Yeung RS Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res. 2002 ; 62: 5645-5650.
32. Kenerson H., Folpe AL, Takayama TK, Yeung RS Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol. 2007 ; 38: 1361-1371.
33. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008 ; 358: 140-151.
34. Patard JJ, Pouessel D., Bensalah K., Culine S. Targeted therapy in renal cell carcinoma. World J Urol. 2008 ; 26: 409-410.
35. Hidai H., Chiba T., Takagi Y., Taki A., Nagashima Y., Kuroko K. Bilateral chromophobe cell renal carcinoma in tuberous sclerosis complex. Int J Urol. 1997 ; 4: 86-89.
36. Sugao H., Takiuchi H., Takatera H., Yokokawa K., Sakurai T., Kobayashi Y. Renal oncocytoma associated with tuberous sclerosis: report of a case [in Japanese]. Hinyokika Kiyo. 1987 ; 33: 1411-1415.
37. Green, JA Renal oncocytoma and tuberous sclerosis. A case report. S Afr Med J. 1987 ; 71 (1). 47-48.